Profil
Janelle Wu was the founder of Feiquanqiu.com, founded in 2014, and served as Chief Executive Officer from 2014 to 2017.
Current jobs include Independent Director at Estrella Immunopharma, Inc., and Chief Metaverse Officer at MetaWorld Entertainment, Inc. since 2022.
Former jobs include Chief Executive Officer at Xlands.com from 2007 to 2012, and Technical Director & Senior Vice President at NetEase, Inc. from 2000 to 2007.
Education includes undergraduate studies at the State University of New York at Albany.
Postes actifs de Janelle Wu
| Sociétés | Poste | Début |
|---|---|---|
| ESTRELLA IMMUNOPHARMA, INC. | Directeur/Membre du Conseil | - |
MetaWorld Entertainment, Inc.
MetaWorld Entertainment, Inc. Internet Software/ServicesTechnology Services Operates as a metaverse entertainment platform company | Corporate Officer/Principal | 01/07/2022 |
Anciens postes connus de Janelle Wu
| Sociétés | Poste | Fin |
|---|---|---|
| NETEASE, INC. | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Formation de Janelle Wu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NetEase, Inc.
NetEase, Inc. Packaged SoftwareTechnology Services Develops an online mobile and PC-client games & provides an online education and live video streaming services | Technology Services |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaWorld Entertainment, Inc.
MetaWorld Entertainment, Inc. Internet Software/ServicesTechnology Services Operates as a metaverse entertainment platform company | Technology Services |
Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biopharmaceutical company focusing on cancer therapeutics to address treatment of blood cancers and solid tumors | Health Technology |
















